Document Detail

Anticancer effects of the p53 activator nutlin-3 in Ewing's sarcoma cells.
MedLine Citation:
PMID:  21334198     Owner:  NLM     Status:  Publisher    
Mutation of p53 is rare in Ewing's sarcoma (ES), suggesting that targeting and activation of wild-type p53 may be an effective therapeutic strategy for ES. The recently developed small-molecule MDM2 inhibitor nutlin-3 restores wild-type p53 function, resulting in the inhibition of cancer cell growth and the induction of apoptosis. In the present study, we explored the responsiveness of ES cell lines with wild-type or mutated p53 to nutlin-3. We found that treatment with nutlin-3 increased p53 level and induced p53 target gene expression (MDM2, p21, PUMA) in ES cells with wild-type p53, but not in ES cells with mutated p53. Consistently, nutlin-3 elicited apoptosis only in wild-type p53 cells, as assessed by caspase-3 activity assay and flow cytometric analyses of mitochondrial depolarisation and DNA fragmentation. In addition, we found nutlin-3 to evoke cellular senescence, indicating that nutlin-3 induces pleiotropic anticancer effects in ES. Furthermore, combined treatment with nutlin-3 and an inhibitor of NF-κB produced synergistic antineoplastic activity in ES cells. Our findings suggest that the direct activation of p53 by nutlin-3 treatment may be a useful new therapeutic approach for patients with ES.
Jürgen Sonnemann; Chithra D Palani; Susan Wittig; Sabine Becker; Friederike Eichhorn; Astrid Voigt; James F Beck
Related Documents :
12497208 - Biological properties of jatrophane polyesters, new microtubule-interacting agents.
10801438 - Two-step positioning of a cleavage furrow by cortexillin and myosin ii.
1175828 - The functional wholes of cells. nucleolar coefficients, mitoses and multinuclearity in ...
7738118 - Inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolae is linked t...
2422478 - Midline b3 serotonin nerves in rat medulla are involved in hypotensive effect of methyl...
8515258 - Receptor-mediated endocytosis of a manganese complex of transferrin into neuroblastoma ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-17
Journal Detail:
Title:  European journal of cancer (Oxford, England : 1990)     Volume:  -     ISSN:  1879-0852     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9005373     Medline TA:  Eur J Cancer     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Ltd. All rights reserved.
University Children's Hospital Jena, Department of Paediatric Haematology and Oncology, Jena, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prognostic significance of interim (18)F-FDG PET/CT after three or four cycles of R-CHOP chemotherap...
Next Document:  Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibi...